- Lung Metastases From Papillary Thyroid Cancer With Persistently Negative Thyroglobulin and Elevated Thyroglobulin Antibody Levels During Radioactive Iodine Treatment and Follow-Up: Long-Term Outcomes and Prognostic Indicators
Zhong-Ling Qiu et al, 2020, Frontiers in Endocrinology CrossRef - Occult lung metastases of papillary thyroid cancer detected in a resected pulmonary arteriovenous malformation specimen
Tomoyoshi Inoue et al, 2022, Respiratory Medicine Case Reports CrossRef - Preclinical evaluation of a novel engineered recombinant human anti-CD44v6 antibody for potential use in radio-immunotherapy
Anja Mortensen et al, 2018, International Journal of Oncology CrossRef - Efficacy of radioiodine therapy for treating 20 patients with pulmonary metastases from differentiated thyroid cancer and a meta-analysis of the current literature
X. Zhang et al, 2018, Clinical and Translational Oncology CrossRef - Delay of initial radioactive iodine therapy beyond 3 months has no effect on clinical responses and overall survival in patients with thyroid carcinoma: A cohort study and a meta‐analysis
Fang Cheng et al, 2022, Cancer Medicine CrossRef - Therapeutic response and long-term outcome of differentiated thyroid cancer with pulmonary metastases treated by radioiodine therapy
Jing Yang et al, 2017, Oncotarget CrossRef - Iodine-131: An Effective Method for Treating Lymph Node Metastases of Differentiated Thyroid Cancer
Ying He et al, 2016, Medical Science Monitor CrossRef